PFMD member Roslyn Schneider, Global Patients’ Affairs Lead at Pfizer discusses emerging trends in the development of meaningful patient engagement in a video filmed at the DIA 2016 conference:
“The most important trends I see emerging today are a stronger commitment to patient engagement and more collaboration. I see collaborations that go across companies, advocacy groups, regulators and academics.
Also, the questions are different now. The questions have moved from ‘Why should we be doing patient engagement?’ to ‘How should we be doing it?’.